✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals

Prevest Denpro Ltd.

PREVEST

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹535 Cr.
P/E
27.26

Prevest Denpro Ltd.

  • Prevest Denpro
  • Medicamen Biotech
  • Kilitch Drugs(India)
  • TJI Pharma - Small Cap

FAQs on Prevest Denpro Ltd. Shareprice

Prevest Denpro has given lower returns compared to its competitors.
Prevest Denpro has grown at ~4.98% over the last 3yrs while peers have grown at a median rate of 8.62%

Prevest Denpro is not expensive.
Latest PE of Prevest Denpro is 27.26, while 3 year average PE is 37.67.
Also latest EV/EBITDA of Prevest Denpro is 19.68 while 3yr average is 30.91.

View FAQ's On Business

Growth Table

  • Prevest Denpro Ltd.
  • Medicamen Biotech
  • Kilitch Drugs(India)

Balance Sheet

  • Prevest Denpro Ltd.
  • Medicamen Biotech
  • Kilitch Drugs(India)

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Prevest Denpro Ltd.
  • Medicamen Biotech
  • Kilitch Drugs(India)

Cash Flow

  • Prevest Denpro Ltd.
  • Medicamen Biotech
  • Kilitch Drugs(India)

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Prevest Denpro Ltd.
  • Medicamen Biotech
  • Kilitch Drugs(India)

Quarterly Results

  • Prevest Denpro Ltd.
  • Medicamen Biotech
  • Kilitch Drugs(India)

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Prevest Denpro Ltd. Financials

Balance sheet of Prevest Denpro is strong.
It shouldn't have solvency or liquidity issues.

Yes, The net debt of Prevest Denpro is increasing.
Latest net debt of Prevest Denpro is -₹67.49 Crs as of Sep-25.
This is greater than Mar-25 when it was -₹121.75 Crs.

Yes, profit is increasing.
The profit of Prevest Denpro is ₹19.61 Crs for TTM, ₹18.16 Crs for Mar 2025 and ₹16.14 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Prevest Denpro latest dividend payout ratio is 6.61% and 3yr average dividend payout ratio is 7.23%

Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech